SANOFI INDIA LIMITED
SANOFI · Pharma · NSE
₹3,245
Current Market Price
Fair Value (DCF)
₹5,356
Discount to FV
+65.0%
Updated just now
YieldIQ Score
40/100
Piotroski F-Score
7/9
Economic Moat
None
Confidence
54%
ROE
43.6%
Debt/Equity
0.02
WACC
9.5%
Market Cap
₹7,474 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
63.1%
Return on capital employed
EV / EBITDA
15.4×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
262.6×
EBIT covers interest
Current Ratio
1.63×
Short-term liquidity
Asset Turnover
1.78×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-12.6%
3-year revenue growth
Revenue CAGR (5Y)
-8.9%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹3,245.1
Bear case
Margin of Safety -1.1%
Implied upside -1.1%
Base case
Margin of Safety +28.3%
Implied upside +39.4%
Bull case
Margin of Safety +35.4%
Implied upside +54.7%
Ratio Trends
SANOFI · last 8 annual periods
ROE
43.6%
ROCE
63.1%
Operating Margin
—
Debt / Equity
0.02×
PE
103.0×
EV / EBITDA
13.7×
Historical Financials
SANOFI · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 NSE_XBRL | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹2957 Cr | ₹2727 Cr | ₹1982 Cr | ₹1989 Cr | ₹1823 Cr | -11.4% |
| EBITDA | — | ₹908 Cr | ₹570 Cr | ₹471 Cr | ₹484 Cr | -14.6% |
| EBIT | ₹1259 Cr | ₹866 Cr | ₹847 Cr | ₹433 Cr | — | -23.4% |
| PAT | ₹944 Cr | ₹621 Cr | ₹603 Cr | ₹414 Cr | ₹327 Cr | -23.3% |
| EPS (diluted) | ₹410.06 | ₹269.47 | ₹261.78 | ₹136.21 | — | -24.1% |
| CFO | ₹559 Cr | ₹399 Cr | ₹230 Cr | ₹462 Cr | ₹438 Cr | -5.9% |
| CapEx | — | ₹-22.2 Cr | ₹-34.3 Cr | ₹-36.4 Cr | ₹-25.7 Cr | — |
| FCF | — | ₹377 Cr | ₹196 Cr | ₹425 Cr | ₹413 Cr | +2.3% |
| Total Assets | — | ₹2072 Cr | ₹1715 Cr | ₹1612 Cr | ₹1255 Cr | -11.8% |
| Total Debt | — | ₹23.6 Cr | ₹19.0 Cr | ₹19.3 Cr | ₹17.8 Cr | -6.8% |
| Shareholders' Equity | — | ₹1276 Cr | ₹1015 Cr | ₹861 Cr | ₹749 Cr | -12.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SANOFI vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
MARKSANS MARKSANS | — | — | Pending | 13.8% | — |
SANOFICONR SANOFICONR | — | — | Pending | 62.5% | — |
RUBICON Rubicon Research Limited | -521.1%-83.9% upside | 40 | Data Limited | 19.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
16 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹1,467.00/sh
Last payout
2026-04-22
₹48.00
Peak payout
₹490.00
Trailing yield
3.79%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. SANOFI INDIA LIMITED (SANOFI.NS) trades at 3245.10 vs a model fair value of 5355.87, a gap of 65.0%. Piotroski F-score: 7/9. Moat label: ...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of SANOFI →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SANOFI →
Compare
Head-to-head with peers
Compare SANOFI side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SANOFINow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.